Common Contracts
4 similar Community Speaker Agreement contracts
Community Speaker AgreementCommunity Speaker Agreement • November 18th, 2021
This is a reference agreement, specific for Community Speaker Agreements, that should be adapted according to the needs of the users. It is based on the “Guiding Principles on Reasonable Agreements between Patient Advocates and Pharmaceutical Companies”, provided by the WECAN project on “Reasonable Legal Agreements between Patient Advocates and Pharmaceutical Companies”, for the most recent version and more information about the guiding principles, please visit www.wecanadvocate.eu/rapp
Community Speaker Agreement between a patient advocate and a pharmaceutical companyCommunity Speaker Agreement • June 18th, 2020
Reference agreement “Community Speaker Agreement” draft version 1.2 (16 June 2020) This is a reference agreement, specific for Community Speaker Agreements, that should be adapted according to the needs of the users. It is based on the “Guiding Principles on Reasonable Agreements between Patient Advocates and Pharmaceutical Companies”, provided by the WECAN project on “Reasonable Legal Agreements between Patient Advocates and Pharmaceutical Companies”, for the most recent version and more information about the guiding principles, please visit http://www.wecanadvocate.eu/rapp www.wecanadvocate.eu/rapp
Community Speaker Agreement between a patient advocate and a pharmaceutical companyCommunity Speaker Agreement • December 17th, 2019
Reference agreement “Community Speaker Agreement” draft version 1.1 (17 December 2019) This is a reference agreement, specific for Community Speaker Agreements, that should be adapted according to the needs of the users. It is based on the “Guiding Principles on Reasonable Agreements between Patient Advocates and Pharmaceutical Companies”, provided by the WECAN project on “Reasonable Legal Agreements between Patient Advocates and Pharmaceutical Companies”, for the most recent version and more information about the guiding principles, please visit www.wecanadvocate.eu/rapp
Community Speaker Agreement between a patient advocate and a pharmaceutical companyCommunity Speaker Agreement • December 17th, 2019
Reference agreement “Community Speaker Agreement” draft version 1.1 (1 December 2019) This is a reference agreement, specific for Community Speaker Agreements, that should be adapted according to the needs of the users. It is based on the “Guiding Principles on Reasonable Agreements between Patient Advocates and Pharmaceutical Companies”, provided by the WECAN project on “Reasonable Legal Agreements between Patient Advocates and Pharmaceutical Companies”, for the most recent version and more information about the guiding principles, please visit www.wecanadvocate.eu/rapp
